EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study

Yangmin Hu, Danyang Li, Gensheng Zhang, Yunjian Dai, Meng Chen, Huifang Jiang, Wei Cui

European Journal of Clinical Microbiology & Infectious Diseases · 2024-05 · 43 (5) · 875-884

DOI: 10.1007/s10096-024-04794-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 05.03.2024. Verfasst von Yangmin Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. zrhym@zju.edu.cn. Hauptthemen laut MEDLINE: Polymyxin B, Anti-Bacterial Agents, Carbapenems, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria (CRGNB) is a life-threatening complication. This study aimed to assess the current practices and clinical outcomes of intravenous (IV) combined with intraventricular (IVT)/intrathecal (ITH) polymyxin B in treating CRGNB intracranial infection.

Methods

A retrospective study was conducted on patients with post-neurosurgical intracranial infection due to CRGNB from January 2013 to December 2020. Clinical characteristics and treatment outcomes were collected and described. Kaplan–Meier survival and multivariate logistic regression analyses were performed.

Results

The study included 114 patients, of which 72 received systemic antimicrobial therapy combined with IVT/ITH polymyxin B, and 42 received IV administration alone. Most infections were caused by carbapenem-resistant Acinetobacter baumannii (CRAB, 63.2%), followed by carbapenem-resistant Klebsiella pneumoniae (CRKP, 31.6%). Compared with the IV group, the IVT/ITH group had a higher cerebrospinal fluid (CSF) sterilization rate in 7 days ( p < 0.001) and lower 30-day mortality ( p = 0.032). In the IVT/ITH group, patients with CRKP infection had a higher initial fever ( p = 0.014), higher incidence of bloodstream infection ( p = 0.040), lower CSF sterilization in 7 days ( p < 0.001), and higher 30-day mortality ( p = 0.005) than those with CRAB infection. Multivariate logistic regression analysis revealed that the duration of IVT/ITH polymyxin B ( p = 0.021) was independently associated with 30-day mortality.

Conclusions

Intravenous combined with IVT/ITH polymyxin B increased CSF microbiological eradication and improved clinical outcomes. CRKP intracranial infections may lead to more difficult treatment and thus warrant attention and further optimized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyxin BAnti-Bacterial AgentsCarbapenemsGram-Negative Bacterial InfectionsGram-Negative BacteriaHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultInjections, SpinalNeurosurgical ProceduresTreatment OutcomeInjections, Intraventricular

Stichwörter der Autor:innen

Central nervous system infectionGram-negative bacteriaIntraventricularMultidrug resistancePolymyxin B

Substanzen

Polymyxin BAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. zrhym@zju.edu.cn.
  • Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. zricu@zju.edu.cn.

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Hu, Y., Li, D., Zhang, G., Dai, Y., Chen, M., Jiang, H., & Cui, W. (2024). Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study. European Journal of Clinical Microbiology & Infectious Diseases, 43(5), 875-884. https://doi.org/10.1007/s10096-024-04794-y

Vancouver

Hu Y, Li D, Zhang G, Dai Y, Chen M, Jiang H, et al. Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study. European Journal of Clinical Microbiology & Infectious Diseases. 2024;43(5):875-884. doi:10.1007/s10096-024-04794-y

BibTeX
@article{Hu2024,
  author = {Hu, Yangmin and Li, Danyang and Zhang, Gensheng and Dai, Yunjian and Chen, Meng and Jiang, Huifang and Cui, Wei},
  title = {Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  volume = {43},
  number = {5},
  pages = {875--884},
  doi = {10.1007/s10096-024-04794-y}
}
Kostenlos starten →